Vaccines and global stability: Achievements and challenges

Expert Review of Vaccines

Volumn 7, Issue 10, 2008, Pages 1457-1460

  Van Der Zeijst, Bernard A M ^a,b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NETHERLANDS VACCINE INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRAX VACCINE; CHICKENPOX VACCINE; DIPHTHERIA VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS B VACCINE; MEASLES VACCINE; MENINGOCOCCUS VACCINE; MUMPS VACCINE; PERTUSSIS VACCINE; PNEUMOCOCCUS VACCINE; POLIOMYELITIS VACCINE; ROTAVIRUS VACCINE; RUBELLA VACCINE; SEVERE ACUTE RESPIRATORY SYNDROME VACCINE; SMALLPOX VACCINE; VACCINE; WART VIRUS VACCINE;

ANTHRAX; ANTIBODY TITER; BACILLUS ANTHRACIS; CHICKENPOX; DIPHTHERIA; DISEASE TRANSMISSION; EDITORIAL; HEALTH PROGRAM; HUMAN; IMMUNIZATION; INDUSTRIALIZATION; INFECTION PREVENTION; MEASLES; MENINGOCOCCOSIS; NONHUMAN; PASSIVE IMMUNIZATION; PERTUSSIS; POLIOMYELITIS; PRIORITY JOURNAL; RABIES VIRUS; RUBELLA; SARS CORONAVIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; SMALLPOX; TETANUS; VACCINATION; VERRUCA VULGARIS; VIRUS INFECTION;

COMMUNICABLE DISEASE CONTROL; DEVELOPED COUNTRIES; DEVELOPING COUNTRIES; HUMANS; VACCINATION; VACCINES;

EID: 57349092978     PISSN: 14760584     EISSN: 17448395     Source Type: Journal    
DOI: 10.1586/14760584.7.10.1457     Document Type: Editorial

References (19)

1. Grimm NB, Faeth SH, Golubiewski NE et al. Global change and the ecology of cities. Science 319(5864), 756-760 (2008).
2. Wolfe ND, Dunavan CP, Diamond J. Origins of major human infectious diseases. Nature 447(7142), 279-283 (2007).
3. Bloom DE, Canning D, Weston M. The value of vaccination. World Economics 6, 15-39 (2005).
4. Struck MM. Vaccine R&D success rates and development times. Nat. Biotechnol. 14(5), 591-593 (1996).
5. Jadhav S, Datla M, Kreeftenberg H, Hendriks J. The Developing Countries Vaccine Manufacturers' Network (DCVMN) is a critical constituency to ensure access to vaccines in developing countries. Vaccine 26(13), 1611-1615 (2008).
6. United States Government Accountability Office. Project Bioshield: actions needed to avoid repeating past problems with procuring new anthrax vaccine and managing the stockpile of licensed vaccine. GAO-08-88 (2007).
7. World Health Organization. The World Health Report 2007 - a safer future: global public health security in the 21st century. WHO, Geneva, Switzerland (2008).
8. Holmes KV. Structural biology. Adaptation of SARS coronavirus to humans. Science 309(5742), 1822-1823 (2005).
9. Lee J-W, McKibbin WJ. Globalization and disease: the case of SARS. Asian Economic Papers 3, 113-131 (2004).
10. Zhu Z, Dimitrov AS, Chakraborti S et al. Development of human monoclonal antibodies against diseases caused by emerging and biodefense-related viruses. Expert. Rev. Anti Infect. Ther. 4(1), 57-66 (2006).
11. Giritch A, Marillonnet S, Engler C et al. Rapid high-yield expression of full-size IgG antibodies in plants coinfected with noncompeting viral vectors. Proc. Natl Acad. Sci. USA 103(40), 14701-14706 (2006).
12. Gerdts V, Littel-van den Hurk SD, Griebel PJ, Babiuk LA. Use of animal models in the development of human vaccines. Future Microbiol. 2, 667-675 (2007).
13. Judenhofer MS, Wehrl HF, Newport DF et al. Simultaneous PET-MRI: a new approach for functional and morphological imaging. Nat. Med. 14(4), 459-465 (2008).
14. Hamaguchi I, Imai J, Momose H et al. Application of quantitative gene expression analysis for pertussis vaccine safety control. Vaccine 26(36), 4686-4696 (2008).
15. Mizukami T, Imai J, Hamaguchi I et al. Application of DNA microarray technology to influenza A/Vietnam/1194/2004 (H5N1) vaccine safety evaluation. Vaccine 26(18), 2270-2283 (2008).
16. Sariol CA, Munoz-Jordan JL, Abel K et al. Transcriptional activation of interferon-stimulated genes but not of cytokine genes after primary infection of rhesus macaques with dengue virus type 1. Clin. Vaccine Immunol. 14(6), 756-766 (2007).
17. Simmons CP, Popper S, Dolocek C et al. Patterns of host genome-wide gene transcript abundance in the peripheral blood of patients with acute dengue hemorrhagic fever. J. Infect. Dis. 195(8), 1097-1107 (2007).
18. Centers for Disease Control and Prevention. Current vaccine shortages & delays 2008 www.cdc.gov/vaccines/vac-gen/shortages/default.htm
19. Vizier Project Team. Vizier Project 2008 www.vizier-europe.org